27th May 2021
- 0 comments
The Riverside Company, a global private investor focused on the smaller end of the middle market, has signed a definitive agreement to sell Greenphire, the global leader in financial lifecycle management software for clinical trials, to Thoma Bravo, a software focused private equity firm.
...In order to read the full story we need you to be registered with us, please click the links below to login or register.